$6.10
+0 (+0%)
At Close: Dec 10, 2025
BioSig Inks Manufacturing Deal with Plexus Corp
10:20am, Thursday, 07'th Oct 2021
Photo by Anna Shvets from Pexels With the recent successes of its PURE EP™ system underway, BioSig Technologies Inc. (NASDAQ: BSGM) has effectively gone global.
BioSig says clinical data acquired by its PURE EP System published in Journal of Cardiovascular Electrophysiology
11:16am, Monday, 04'th Oct 2021
BioSig Technologies Inc. has announced that clinical data acquired by its PURE EP System has been published in the Journal of Cardiovascular Electrophysiology.
BioSig Technologies selects Wisconsin-based Plexus Corp. as its manufacturing partner
10:22am, Tuesday, 28'th Sep 2021
BioSig Technologies Inc. said it has entered into a manufacturing and professional services agreement with Plexus Corp.
BioSig Selects Plexus Corp. as its Manufacturing Partner
09:15am, Tuesday, 28'th Sep 2021
Global leader in complex product design, supply chain, manufacturing, and aftermarket services to support the Company's growth Global leader in complex product design, supply chain, manufacturing, and
BioSig's PURE EP Aims to Address Unmet Needs of Afib Patients
09:47am, Thursday, 23'rd Sep 2021
Image by PublicDomainPictures from Pixabay An estimated 33.5 million individuals worldwide and nearly 2.7 million people in the U.S. live with an often silent, untreated medical issue.
BioSig Technologies appoints medical-device industry executive James Barry as independent board director
12:44pm, Tuesday, 21'st Sep 2021
BioSig Technologies Inc, which is commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, has announce
BioSig Technologies, Inc. Appoints Medical Device Industry Leader to its Board of Directors
10:30am, Tuesday, 21'st Sep 2021
James J. Barry, Ph.D. will join as an Independent Director as Company expands clinical footprint with its signal processing technology for arrhythmia care James J. Barry, Ph.D. will join as an Indepen
BioSig Expands in Electrophysiology with St. Elizabeth's Medical Center Evaluation
07:40am, Friday, 17'th Sep 2021
Increasing its ever-growing presence in the cardiac electrophysiology space, BioSig Technologies (NASDAQ: BSGM) will be installing one of its new PURE EP systems in St. Elizabeth's Medical Center in B
BioSig to install PURE EP System for evaluation at St. Elizabeth's Medical Center in Boston
09:58am, Monday, 13'th Sep 2021
BioSig Technologies Inc said it would install a PURE EP System for evaluation at St. Elizabeth's Medical Center in Boston. The company said it initiated the new evaluation program under the leaders
BioSig Technologies says to participate in The Mark E. Josephson Twenty-Eight Annual State-of-the-Art Arrhythmia Symposium
11:28am, Tuesday, 31'st Aug 2021
BioSig Technologies, Inc. said it has been invited to participate in The Mark E.
BioSig Confirmed as a Participant of The Mark E. Josephson Twenty-Eight Annual State-of-the-Art Arrhythmia Virtual Symposium
10:00am, Tuesday, 31'st Aug 2021
Physician-only event, organized by the University of Pennsylvania, is a tribute to the pioneer of cardiac electrophysiology Physician-only event, organized by the University of Pennsylvania, is a trib
BioSig's Signal Processing System for Arrhythmia Care To Be Featured At The Kansas City Heart Rhythm Symposium
11:00am, Thursday, 19'th Aug 2021
A physician user from a leading medical center of excellence will present the technology and discuss recent clinical data A physician user from a leading medical center of excellence will present the
BioSig Technologies looking to unlock the future of bioelectronic medicine
06:20am, Monday, 09'th Aug 2021
Using targeted electrical signals to harness the body's natural mechanisms to diagnose and treat a range of diseases Has commercialized its first product, a biomedical signal processing platform call
Confirmed speakers include the largest technology users from Mayo Clinic, Texas Cardiac Arrhythmia Institute, and University of Pennsylvania Confirmed speakers include the largest technology users fro
BioSig Technologies expands Texas clinical footprint for its PURE EP technology for arrhythmia care
03:51pm, Tuesday, 13'th Jul 2021
BioSig Technologies Inc (NASDAQ:BSGM) has announced the signing of a new agreement for the clinical evaluation of the company's PURE EP technology for arrhythmia care at Medical City North Hills in No
Sign In
Buy BSGM